Initiating digoxin in AF patients associated with early hazard of sudden death
ACC 2017 A substudy of ARISTOTLE showed that new users of digoxin had a four-fold risk of sudden death, and higher plasma digoxin levels were associated with higher risk, also in AF patients who used digoxin at baseline.
This video was recorded during ACC 2017, March 17-19 in Washington, DC, USA. PACE-cme did not receive financial support for the production of this video.
The educational content reflects the personal opinion of the expert.
Dr. Renato Lopes - Duke University Medical Centre, Durham, NC, USA